XML 66 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Significant Customers and Concentration of Credit Risk
 12 Months Ended
Dec. 31, 2013
Risks and Uncertainties [Abstract]  
Significant Customer and Concentration of Credit Risk
Significant Customers and Concentration of Credit Risk

The company is engaged in the business of developing and commercializing pharmaceutical products. The company has one commercial product, Abstral, available in six dosing strengths, and all sales reported are in the United States.

The company had product sales to three customers that represented more than 10% of revenue for the three months ended December 31, 2013. Customers A, B, and C had product shipments that accounted for 34%, 26%, and 25%, respectively, of sales for the year ended December 31, 2013. No revenue was recognized prior to the year ended December 31, 2013.

The company had accounts receivable from three customers that represented more than 10% of total accounts receivable balance as of December 31, 2013. Customers A, B, and C had accounts receivable of 54%, 11%, and 25%, respectively, of the total accounts receivable balance as of December 31, 2013. There was no accounts receivable balance as of December 31, 2012.